Showing results (351-360 of 397) with videos related to

Sort By:
Pageof 40
Pediatric Blood & Cancer|March 25, 2021
Quality of life is an important indication for second-line treatment in children with immune thrombocytopeniaKristin A Shimano, Cindy Neunert, James B Bussel, et al.
Haematologica|April 22, 2014
Rituximab and three dexamethasone cycles provide responses similar to splenectomy in women and those with immune thrombocytopenia of less than two years durationJames B Bussel, Christina S Lee, Caroline Seery, et al.
Blood|August 5, 2020
Identification of occult cerebral microbleeds in adults with immune thrombocytopeniaNichola Cooper, Melanie A Morrison, Camelia Vladescu, et al.
Lancet (London, England)|April 23, 2016
Romiplostim in children with immune thrombocytopenia: a phase 3, randomised, double-blind, placebo-controlled studyMichael D Tarantino, James B Bussel, Victor S Blanchette, et al.
Platelets|December 8, 2017
Effect of thrombopoietin receptor agonists on markers of coagulation and P-selectin in patients with immune thrombocytopeniaLamya Garabet, Waleed Ghanima, Christine Monceyron Jonassen, et al.
Health and Quality of Life Outcomes|February 12, 2008
Impact of chronic Immune Thrombocytopenic Purpura (ITP) on health-related quality of life: a conceptual model starting with the patient perspectiveSusan D Mathias, Sue K Gao, Kimberly L Miller, et al.
Blood|March 11, 2011
Platelet production and platelet destruction: assessing mechanisms of treatment effect in immune thrombocytopeniaSarah J Barsam, Bethan Psaila, Marc Forestier, et al.
Blood|October 17, 2014
IRAK-4 and MyD88 deficiencies impair IgM responses against T-independent bacterial antigensPaul J Maglione, Noa Simchoni, Samuel Black, et al.
Lancet (London, England)|October 1, 2023
Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trialCatherine M Broome, Vickie McDonald, Yoshitaka Miyakawa, et al.
Science Translational Medicine|September 14, 2018
Thrombopoietin receptor-independent stimulation of hematopoietic stem cells by eltrombopagYun-Ruei Kao, Jiahao Chen, Swathi-Rao Narayanagari, et al.
Pageof 40